Decode 100%
of Ultrasound data

Software-defined ultrasound to unlock biomarkers

Human and computational
intelligence to craft ultrasound engine

01

Collect unique ultrasound data

Capture unprecedented data such as 3D cerebral CEUS raw data and preserve the rich insights now modern ultrasound hardware can deliver. Build unique datasets.

02

Generate new ultrasound imaging modes

Train proprietary algorithms to unlock richer, higher-resolution images previously inaccessible enabling, for instance, real-time brain imaging anywhere, anytime.

03

Extract clinically-relevant biomarkers

By leveraging 3D structured data, develop quantitative biomarkers that deliver rapid, objective results without the user dependency traditionally associated with ultrasound.

A first generation of
biomarkers under development

RS USP

The delayed ischemic risk score predicts the likelihood of delayed brain damage following severe neurological injury. In intensive care units, this will help doctors to adapt their therapeutic strategy in patients with a high-risk profile.

RS LVO

The arterial permeability index aims to offer a crucial method to evaluate blood supply to the brain. It assesses whether there are any blockages in the major blood vessels supplying the brain. This aims to assist doctors in determining whether a patient requires specialized treatment to clear any blocked blood vessels.

Stealth scores

Cutting-edge biomarkers poised to revolutionize healthcare diagnostics for brain application and beyond.

*biomarkers in development, not available for sale

We are busy integrating our engine
into a first clinical platform

STEP 1

PAST

Theoretical concepts

First identifications of potential improvements through software-based ultrasound technology

STEP 2

PAST

First human data

Proprietary ultrasound data uniquely captured through Resolve Stroke’s own platform, enabling insights erased with conventional systems.

STEP 3

TODAY

First clinical software

First end-to-end clinical product developed.
Unique datasets being built (3D cerebral blood flow).

STEP 4.a

TOMORROW

Use cases expansion

Expanding clinical applications beyond Intensive Care Units by leveraging Resolve Stroke’s installed product base and engaged physician community.

STEP 4.b

TOMORROW

Biomarkers

Leading the next leap in non-molecular diagnostics with user-independent, structured, and information-rich ultrasound data.

Our latest publications

Publications

Software-Defined Ultrasound : Part 1

V. Hingot, Ph.D., O. Couture Ph.D, S. Bodard MD Ph.D.

Software-Defined Ultrasound is shaping new horizons in medical imaging. This article explores foundational principles of how ultrasound scanner architecture has evolved toward GPU-based processing, enabling advanced algorithms and machine learning techniques to enhance image quality and clinical benefits.

Read here
Publications

AI in ultrasound imaging: Part 2 – Can Neuro be the next big thing?

V. Hingot, Ph.D., O. Couture Ph.D

AI is revolutionizing radiology, simplifying and speeding up complex workflows—especially in time-sensitive areas like neuroimaging. Although AI for ultrasound has faced challenges due to the nature of the ultrasound technology and practice, remarkable progress is being made.

Alongside large traditional manufacturers, new players like Butterfly Network, Inc., Clarius Mobile Health, Exo, Forest Neurotech, Sonologi, Inc. and others, are pushing the boundaries of what is possible with ultrasound.

In this article, we discuss the place of AI in ultrasound practice and how new data could be a game-changer for neuro ultrasound.

Read here
Publications

Quantum leap in ultrasound imaging Part 3: Biomarker discovery

V. Hingot, Ph.D., O. Couture Ph.D, S. Bodard MD Ph.D.

In a broad sense, quantitative imaging refers to the extraction and use of numerical features from medical images. According to the Quantitative Imaging Biomarker Alliance (QIBA), a biomarker is “an objective characteristic derived from an in vivo image measured on a ratio or interval scale as indicators of normal biological processes, pathogenic processes, or a response to a therapeutic intervention.

Available soon